with an amazing volume-enhancing power, devoted to:

• the treatment of folds and facial depressions
• work on the face’s contours and reliefs
• increase lip volume.

With Fortélis Extra, developed and marketed in 2007, Anteis Aesthetics, after having created a new era in aesthetic medicine, adds a new dimension to its ranges of products designed to rehydrate, fill and model like no other.

1976 |	Collagen ----------------------------------------------------------------------------------------------------------------------
1996 |	First generation of resorbable fillers developed from hyaluronic acid of animal origin ----------------------------------------------------------------------------------------------------------------------
1996 |	Second generation of resorbable fillers developed from hyaluronic acid of non-animal origin – biphasic products ----------------------------------------------------------------------------------------------------------------------
2000 |	Third generation of resorbable fillers developed from hyaluronic acid of non-animal origin – monophasic monodensified products ----------------------------------------------------------------------------------------------------------------------
2005 |	Fourth generation of resorbable gels developed from hyaluronic acid of non-animal origin – Esthélis and CPM technology create a genuine revolution in the world of aesthetic medicine. ----------------------------------------------------------------------------------------------------------------------
2007 |	Anteis Aesthetics launches Fortélis Extra, a resorbable implant developed from hyaluronic acid of non-animal origin. Fortélis Extra’s perfectly adapted elasticity makes it possible to work on the folds and to model the face’s contours and reliefs.

Thanks to its perfectly adapted elasticity, Fortélis Extra offers amazing modelling possibilities, an Extra-ordinary volume-enhancing effect and "real-lasting" results. 



See detailed information and key indications of Fortélis Extra.

2. Anteis, a major asset for Fortélis Extra!

Fortélis Extra benefits from the same rigor and the same requirement level that Anteis, 

Swiss company, applies to all its products.

• The least toxic cross-linking agent on the market (BDDE)
• Low endotoxin and protein residue rates
• An adapted pH and osmolarity for better acceptance of the implant by the dermis.